The agenda for the 1 July 2015 TC meeting is now available. The Commission will consider the following technologies:

• Voraxapar sulfate (Zontivity) - new medicine
• Immunoglobulin (human) (HyQvia) - new blood product
• Secukinumab (Cosentyx) - new medicine
• Proteolytic enzymes (Nexobrid) - new medicine

For more details, go to: http://www.has-sante.fr [French]